Archivio Categoria: series B

Idelic Raises $20M in Series B Financing

USA – Idelic, Inc., a Pittsburgh, PA-based provider of commercial trucking analytics and driver management solutions, closed a $20m Series B funding round. The round was led by Highland Capital Partners with participation from AXA Venture Partners and previous investors Birchmere Ventures, Origin Ventures, TDF Ventures, and SaaS Venture Capital. In conjunction with the financing, Craig Driscoll of […]

Linktree Raises $45M in Series B Funding

USA – Linktree, a Melbourne, Australia-based linking platform, raised $45M in Series B funding. The round was co-led by Index Ventures, and Coatue, with participation from returning investors AirTree Ventures and Insight Partners. Coatue Chairman Dan Rose will join Linktree’s Board of Directors. The company intends to use the funds to expand operations and open multi-location creator […]

Holberton Raises $20M in Series B Funding

USA – Holberton, a San Francisco, CA-based software engineering education company, raised $20m in Series B funding. The round was led by Redpoint eventures with new investor Pearson Ventures and participation by existing investors Daphni, Imaginable Futures, Reach Capital and Trinity Ventures.The company intends to use the funds to continue to expand operations and its business reach.Led by Julien Barbier, CEO and […]

Vaccitech Raises $168M in Series B Financing

UK – Vaccitech Ltd, an Oxford, UK – based clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer, raised $168m in Series B financing. The round was led by M&G Investment Management (part of M&G plc), with further participation from new […]

Autobooks Secures $25M in Series B Funding

USA – Autobooks, a Detroit, MI-based small business payment and accounting services platform, raised $25m in Series B financing. The round was led by MissionOG with participation from Renaissance Venture Capital, Detroit Venture Partners and Draper Triangle, along with TD Bank Group.The company intends to use the funds to continue to expand operations domestically, as well as enter international markets, accelerate product […]

Hi Marley Raises $25M Series B Funding Round

USA – BOSTON, MA, Hi Marley today announced the company has closed a $25 million Series B financing round. Hi Marley, creators of the only intelligent communication platform built for the insurance industry by people who know insurance, today announced the company has closed a $25 million Series B financing round. The investment was led […]

Tetrate Raises $40M in Series B

USA – SAN FRANCISCO, CA, Tetrate announced it has raised $40 million in a Series B funding round led by Sapphire Ventures. Tetrate announced it has raised $40 million in a Series B funding round led by Sapphire Ventures. Other new investors, Scale Venture Partners and NTTVC, and existing investors, Dell Technologies Capital, Intel Capital, […]

Cybrexa Therapeutics Closes $25M in Series B

USA – NEW HAVEN, CT, Cybrexa Therapeutics announced the completion of its $25 million Series B financing. Cybrexa Therapeutics, an oncology-focused biotechnology company developing a new class of therapeutics through its alphalex Peptide Drug Conjugate (PDC) tumor targeting platform, today announced the completion of its $25 million Series B financing. The financing included HighCape Capital […]

Privacera Nabs $50M Series B Round

USA – FREMONT, CA, Privacera today announced that it has secured $50 million in Series B funding. Privacera, the cloud data governance and security leader founded by the creators of Apache Ranger™, today announced that it has secured $50 million in funding to meet the unprecedented demand for its cloud-based data governance and security solution. […]

Amunix Raises $117M in Series B Financing

USA – Amunix Pharmaceuticals, Inc., a South San Francisco, CA-based biopharmaceutical company focused on developing masked, protease-activated immune-oncology therapeutics to bring the promise of these potent therapies to patients with solid tumor cancers, raised $117m in Series B financing. The round was led by Viking Global Investors with participation from a premier syndicate of funds, […]